 |
|
|
| |
Virologic and Immunologic Responses to Raltegravir and Dolutegravir in GALT of HIV+ Men and Women
|
| |
| |
Reported by Jules Levin
17th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, June 8-10, 2016, Washington DC
Michael D Weber, Elizabeth Andrews, Heather A Prince, Craig Sykes, Nicholas J Shaheen, Ryan D Madanick, Evan Dellon, Kristina De Paris, Julie AE Nelson, Cynthia Gay, and Angela DM Kashuba
Mike Weber, PharmD
Clinical Research and Drug Development Fellow
University of North Carolina
June 9th, 2016
|
| |
|
|
|
|
|
